Klaviyo Inc
For the period ended Dec 31, 2024. Filed Feb 19, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Feb 19, 2025
KVYO$20.43-1.9%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 8. Consolidated Balance Sheets
Consolidated Balance Sheets
| As of, | ||
|---|---|---|
| December 31, 2024 | December 31, 2023 | |
| Assets | ||
| Current assets: | ||
| Cash and cash equivalents | $881,473 | $738,562 |
| Restricted cash | 375 | 409 |
| Accounts receivable, net of allowance for doubtful accounts | 43,095 | 23,076 |
| Deferred contract acquisition costs, current | 20,544 | 15,198 |
| Prepaid expenses and other current assets | 34,262 | 26,244 |
| Total current assets | 979,749 | 803,489 |
| Property and equipment, net | 48,200 | 43,450 |
| Right-of-use assets, net | 42,917 | 36,987 |
| Deferred contract acquisition costs, non-current | 32,527 | 23,177 |
| Restricted cash, non-current | 739 | 686 |
| Prepaid marketing expense | 153,346 | 173,844 |
| Other non-current assets | 15,830 | 7,417 |
| Total assets | $1,273,308 | $1,089,050 |
| Liabilities and Stockholders’ Equity | ||
| Current liabilities: | ||
| Accounts payable | $14,579 | $13,597 |
| Accrued expenses | 99,828 | 62,838 |
| Lease liabilities, current | 20,989 | 14,081 |
| Deferred revenue | 64,497 | 40,100 |
| Total current liabilities | 199,893 | 130,616 |
| Lease liabilities, non-current | 32,449 | 37,498 |
| Other non-current liabilities | 6,979 | 6,159 |
| Total liabilities | 239,321 | 174,273 |
| Stockholders’ Equity | ||
| Preferred stock: $0.001 par value; 100,000,000 and 100,000,000 shares authorized; 0 and 0 shares issued; 0 and 0 shares outstanding at December 31, 2024 and 2023, respectively. | — | — |
| Series A common stock: $0.001 par value; 3,000,000,000 and 3,000,000,000 shares authorized; 88,956,301 and 40,841,834 shares issued and outstanding at December 31, 2024 and 2023, respectively. | 89 | 41 |
| Series B common stock: $0.001 par value; 350,000,000 and 350,000,000 shares authorized; 183,801,332 and 218,524,009 shares issued and outstanding at December 31, 2024 and 2023, respectively. | 184 | 219 |
| Additional paid-in capital | 1,878,899 | 1,713,560 |
| Accumulated deficit | (845,185) | (799,043) |
| Total stockholders’ equity | 1,033,987 | 914,777 |
| Total liabilities and stockholders’ equity | $1,273,308 | $1,089,050 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.